209 related articles for article (PubMed ID: 33863366)
1. A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.
Jones W; Gong B; Novoradovskaya N; Li D; Kusko R; Richmond TA; Johann DJ; Bisgin H; Sahraeian SME; Bushel PR; Pirooznia M; Wilkins K; Chierici M; Bao W; Basehore LS; Lucas AB; Burgess D; Butler DJ; Cawley S; Chang CJ; Chen G; Chen T; Chen YC; Craig DJ; Del Pozo A; Foox J; Francescatto M; Fu Y; Furlanello C; Giorda K; Grist KP; Guan M; Hao Y; Happe S; Hariani G; Haseley N; Jasper J; Jurman G; Kreil DP; Łabaj P; Lai K; Li J; Li QZ; Li Y; Li Z; Liu Z; López MS; Miclaus K; Miller R; Mittal VK; Mohiyuddin M; Pabón-Peña C; Parsons BL; Qiu F; Scherer A; Shi T; Stiegelmeyer S; Suo C; Tom N; Wang D; Wen Z; Wu L; Xiao W; Xu C; Yu Y; Zhang J; Zhang Y; Zhang Z; Zheng Y; Mason CE; Willey JC; Tong W; Shi L; Xu J
Genome Biol; 2021 Apr; 22(1):111. PubMed ID: 33863366
[TBL] [Abstract][Full Text] [Related]
2. Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.
Gong B; Li D; Kusko R; Novoradovskaya N; Zhang Y; Wang S; Pabón-Peña C; Zhang Z; Lai K; Cai W; LoCoco JS; Lader E; Richmond TA; Mittal VK; Liu LC; Johann DJ; Willey JC; Bushel PR; Yu Y; Xu C; Chen G; Burgess D; Cawley S; Giorda K; Haseley N; Qiu F; Wilkins K; Arib H; Attwooll C; Babson K; Bao L; Bao W; Lucas AB; Best H; Bhandari A; Bisgin H; Blackburn J; Blomquist TM; Boardman L; Burgher B; Butler DJ; Chang CJ; Chaubey A; Chen T; Chierici M; Chin CR; Close D; Conroy J; Cooley Coleman J; Craig DJ; Crawford E; Del Pozo A; Deveson IW; Duncan D; Eterovic AK; Fan X; Foox J; Furlanello C; Ghosal A; Glenn S; Guan M; Haag C; Hang X; Happe S; Hennigan B; Hipp J; Hong H; Horvath K; Hu J; Hung LY; Jarosz M; Kerkhof J; Kipp B; Kreil DP; Łabaj P; Lapunzina P; Li P; Li QZ; Li W; Li Z; Liang Y; Liu S; Liu Z; Ma C; Marella N; Martín-Arenas R; Megherbi DB; Meng Q; Mieczkowski PA; Morrison T; Muzny D; Ning B; Parsons BL; Paweletz CP; Pirooznia M; Qu W; Raymond A; Rindler P; Ringler R; Sadikovic B; Scherer A; Schulze E; Sebra R; Shaknovich R; Shi Q; Shi T; Silla-Castro JC; Smith M; López MS; Song P; Stetson D; Strahl M; Stuart A; Supplee J; Szankasi P; Tan H; Tang LY; Tao Y; Thakkar S; Thierry-Mieg D; Thierry-Mieg J; Thodima VJ; Thomas D; Tichý B; Tom N; Garcia EV; Verma S; Walker K; Wang C; Wang J; Wang Y; Wen Z; Wirta V; Wu L; Xiao C; Xiao W; Xu S; Yang M; Ying J; Yip SH; Zhang G; Zhang S; Zhao M; Zheng Y; Zhou X; Mason CE; Mercer T; Tong W; Shi L; Jones W; Xu J
Genome Biol; 2021 Apr; 22(1):109. PubMed ID: 33863344
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics.
Misyura M; Zhang T; Sukhai MA; Thomas M; Garg S; Kamel-Reid S; Stockley TL
J Mol Diagn; 2016 Nov; 18(6):842-850. PubMed ID: 27770852
[TBL] [Abstract][Full Text] [Related]
4. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.
Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F
Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599
[TBL] [Abstract][Full Text] [Related]
5. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
Shin H; Sa JK; Bae JS; Koo H; Jin S; Cho HJ; Choi SW; Kyoung JM; Kim JY; Seo YJ; Joung JG; Kim NKD; Son DS; Chung J; Lee T; Kong DS; Choi JW; Seol HJ; Lee JI; Suh YL; Park WY; Nam DH
Cancer Res Treat; 2020 Jan; 52(1):41-50. PubMed ID: 31096737
[TBL] [Abstract][Full Text] [Related]
6. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
[TBL] [Abstract][Full Text] [Related]
7. Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement.
Sireci AN; Aggarwal VS; Turk AT; Gindin T; Mansukhani MM; Hsiao SJ
J Mol Diagn; 2017 Mar; 19(2):277-287. PubMed ID: 28024947
[TBL] [Abstract][Full Text] [Related]
8. Ultra-deep multi-oncopanel sequencing of benchmarking samples with a wide range of variant allele frequencies.
Gong B; Kusko R; Jones W; Tong W; Xu J
Sci Data; 2022 Jun; 9(1):288. PubMed ID: 35680918
[TBL] [Abstract][Full Text] [Related]
9. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.
Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S
BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033
[TBL] [Abstract][Full Text] [Related]
10. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
11. Clinical Validation of a Cell-Free DNA Gene Panel.
Cheng J; Cao Y; MacLeay A; Lennerz JK; Baig A; Frazier RP; Lee J; Hu K; Pacula M; Meneses E; Robinson H; Batten JM; Brastianos PK; Heist RS; Bardia A; Le LP; Iafrate AJ
J Mol Diagn; 2019 Jul; 21(4):632-645. PubMed ID: 31026600
[TBL] [Abstract][Full Text] [Related]
12. Consistency and reproducibility of large panel next-generation sequencing: Multi-laboratory assessment of somatic mutation detection on reference materials with mismatch repair and proofreading deficiency.
Wang D; Zhang Y; Li R; Li J; Zhang R
J Adv Res; 2023 Feb; 44():161-172. PubMed ID: 36725187
[TBL] [Abstract][Full Text] [Related]
13. DEEPGEN
Hermann BT; Pfeil S; Groenke N; Schaible S; Kunze R; Ris F; Hagen ME; Bhakdi J
Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33808158
[TBL] [Abstract][Full Text] [Related]
14. Inter-lab concordance of variant classifications establishes clinical validity of expanded carrier screening.
Kaseniit KE; Collins E; Lo C; Moyer K; Mar-Heyming R; Kang HP; Muzzey D
Clin Genet; 2019 Sep; 96(3):236-245. PubMed ID: 31170325
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA.
Weerts MJA; Timmermans EC; van de Stolpe A; Vossen RHAM; Anvar SY; Foekens JA; Sleijfer S; Martens JWM
Neoplasia; 2018 Jul; 20(7):687-696. PubMed ID: 29842994
[TBL] [Abstract][Full Text] [Related]
16. A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors.
Conroy JM; Pabla S; Glenn ST; Seager RJ; Van Roey E; Gao S; Burgher B; Andreas J; Giamo V; Mallon M; Lee YH; DePietro P; Nesline M; Wang Y; Lenzo FL; Klein R; Zhang S
PLoS One; 2021; 16(12):e0260089. PubMed ID: 34855780
[TBL] [Abstract][Full Text] [Related]
17. Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene.
Gould GM; Grauman PV; Theilmann MR; Spurka L; Wang IE; Melroy LM; Chin RG; Hite DH; Chu CS; Maguire JR; Hogan GJ; Muzzey D
BMC Med Genet; 2018 Sep; 19(1):176. PubMed ID: 30268105
[TBL] [Abstract][Full Text] [Related]
18. Standardized decision support in next generation sequencing reports of somatic cancer variants.
Dienstmann R; Dong F; Borger D; Dias-Santagata D; Ellisen LW; Le LP; Iafrate AJ
Mol Oncol; 2014 Jul; 8(5):859-73. PubMed ID: 24768039
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Sequencing Concordance Analysis of Comprehensive Solid Tumor Profiling between a Centralized Specialty Laboratory and the Decentralized Personal Genome Diagnostics elio Tissue Complete Kitted Solution.
Deak KL; Jackson JB; Valkenburg KC; Keefer LA; Robinson Gerding KM; Angiuoli SV; Datto MB; McCall SJ
J Mol Diagn; 2021 Oct; 23(10):1324-1333. PubMed ID: 34314880
[TBL] [Abstract][Full Text] [Related]
20. Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing-Based Comprehensive Tumor Profiling in Liquid Biopsy Samples.
Harter J; Buth E; Johaenning J; Battke F; Kopp M; Zelba H; Schulze M; Koedding J; Biskup S
J Mol Diagn; 2024 Jan; 26(1):61-72. PubMed ID: 37865292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
